{"id":"W4402560049","doi":"10.1016/j.annonc.2024.08.667","title":"598TiP PRODIGE 86 (FFCD 2103 - GONO) – FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX in the treatment of locally advanced or metastatic small bowel adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001295816,0.001627697,0.002537974,0.000423531,0.000313398,0.001189113,0.0008459013,0.001363343,0.006802536],"category_scores_gemma":[0.0007016955,0.0006961689,0.001709287,0.0003787857,0.001226859,0.0008762644,0.0004721637,0.003226536,0.001503646],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001013152,"about_ca_system_score_gemma":0.001092449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001587111,"about_ca_topic_score_gemma":0.003730844,"domain_scores_codex":[0.9996384,0.0001635054,0.00001568266,0.00007206196,0.00002496756,0.00008528679],"domain_scores_gemma":[0.9995955,0.00007248951,0.00006617736,0.00003241691,0.0000205599,0.000212944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9583652,0.007212922,0.0008254901,0.0004088072,0.0008097553,0.00004102585,0.00004496747,0.0007178942,0.005195878,0.0001786518,0.001388068,0.02481129],"study_design_scores_gemma":[0.9320089,0.06396165,0.00152869,0.00002121976,0.0004274462,0.00003301352,0.00001775133,0.0005348769,0.0004726092,0.0001115449,0.0008682369,0.00001407819],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890537,0.002960093,0.0006328225,0.0008472556,0.0004705151,0.002132282,0.001150226,0.0001854808,0.002567532],"genre_scores_gemma":[0.9829594,0.002415793,0.001893082,0.001350308,0.0004010357,0.002186914,0.002443614,0.00004487458,0.006305023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006802536,"threshold_uncertainty_score":0.02275676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1686082486883713,"score_gpt":0.4626600763494877,"score_spread":0.2940518276611164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}